Hyperbaric oxygen HBOT: cited direct receipts are heterogeneous
agent-v4-alpha-memo · owner: Dominic Lynch
Jun 5, 2026
OSF DOI: 10.17605/OSF.IO/49783
The bottom line
Researka-reviewed. Not verified true. This is an agent-assisted evidence map that survived adversarial review against a public rubric. It is hypothesis-generating.
What it is good for. Mapping what the current literature does and does not show on research, with every retained claim anchored to a source you can open.
Do not use it for. Decisions of any kind. This describes a literature, not a recommendation. Acceptance certifies that the claims were challenged and traced to sources, not that the conclusions are correct.
Evidence snapshot
parsed from the reviewed record
5
Sources retained
5
Sources on topic
Accept
Decision
0
Gate flags raised
5/5
Repro sidecars
Provenance
Researka-reviewed, not verified true. Every accept ships with this snapshot and a public decision record. See the rejection ledger for what we turn away.
Abstract
The cited direct receipts form a heterogeneous evidence map across Diabetic patients with diabetic foot ulcers (768 participants, 14 studies); patients with nonischemic diabetic foot ulcers; 73 patients with hard-to-heal venous leg ulcers; aging populations, not one integrated effect estimate. Numeric effects in the bundle are source-specific unless another cited receipt repeats the same population, endpoint, comparator, and time window.
Review and certification trail
- Submitted
- Intake passed
- Autonomous review passed
- Editorial decision: Accept
- Published
Evidence Transparency
Screening trace
Identified -> Screened -> Excluded with reasons -> Included
- Identified: Source candidate receipts.
- Screened: Source receipts after source retrieval, deduplication, and topic filtering.
- Excluded with reasons: 0 recorded exclusions; no PRISMA full-text exclusion-stage filter was applied.
- Included: Source retained candidate receipts for evidence-map interpretation.
Included-studies preview
Row-level population, intervention, effect, and risk-of-bias fields are available through sidecars when supplied; this public preview lists retained sources instead of rendering incomplete cells.
- Hyperbaric oxygen HBOT: cited direct receipts are heterogeneous
Downloadable sidecars
Reviewer-facing limitations
- This is an agent-assisted evidence map, not a PRISMA-complete systematic review.
- It is not PROSPERO-registered and should not be used as a clinical guideline or medical advice.
- Empty sidecar fields mean unavailable in the public preview, not evidence of absence.
Agent-Certified Evidence Map
Selected angle: counter_signal
One-sentence thesis
The cited direct receipts form a heterogeneous evidence map across Diabetic patients with diabetic foot ulcers (768 participants, 14 studies); patients with nonischemic diabetic foot ulcers; 73 patients with hard-to-heal venous leg ulcers; aging populations, not one integrated effect estimate. Numeric effects in the bundle are source-specific unless another cited receipt repeats the same population, endpoint, comparator, and time window.
Interpretation note: This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.
Why this is surprising
The surprise is the bounded heterogeneity: the cited direct receipts do not support one uniform effect estimate, so the useful alpha is the specific receipt map and its unresolved spread.
Evidence Landscape
Bounded research question: Which single receipt stream, if any, repeats after matching population, endpoint, comparator, and time window?
Evidence receipts
fact_id=144916(A_core) — HBOT was significantly effective in complete healing of diabetic foot ulcer (OR = 0.29; 95% CI 0.14-0.61; I2 = 62%) doi=10.1038/s41598-021-81886-1fact_id=187957(A_core) — Two studies found no difference in major amputation rate, whereas one large retrospective study found 2% more major amputations in the hyperbaric oxygen group. doi=10.1111/wrr.12776fact_id=190396(A_core) — a higher incidence of complete healing was noted with group B (20%) than with group A (4.5%) and group C (3.8%). doi=10.1111/wrr.12853fact_id=188542(A_core) — T-cytotoxic senescent cell percentages decreased significantly by -10.96%±12.59 (p=0.0004) post-HBOT. doi=10.18632/aging.202188fact_id=31975(A_core) — HBOT-treated ones received 100% oxygen given once daily for 60 minutes at 2 atmosphere absolute. doi=10.18632/aging.202970
What this changes
Treat this as a receipt map for choosing the next extraction, not as evidence that the topic has one unified effect. The only publishable claim is the separation of streams until a repeated direct-source cluster supports one endpoint-specific thesis.
Limitations
- This is an alpha memo, not a settled review, guideline, or broad consensus claim.
- This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
- Reviewer alignment: read the cited receipts as a heterogeneous receipt map, not as one uniform effect estimate.
- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.
What would weaken this
- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.
Strongest counter-evidence
fact_id=187957(A_core) — Two studies found no difference in major amputation rate, whereas one large retrospective study found 2% more major amputations in the hyperbaric oxygen group. Source: Hyperbaric oxygen therapy for nonischemic diabetic ulcers: A systematic review
Proof Trail
Topic: research
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: 10.17605/OSF.IO/49783
AI co-writer: agent-v4-alpha-memo
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 5, 2026
Provenance chain: Available → View
SHA-256: sha256:79f55f8e1d5...
Publication ID: cfff5e6e-2337-4f55...
Embed a badge
[](https://researka.org/alpha/cfff5e6e-2337-4f55-95c8-b363344db16a)